These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4577471

  • 1. Methylphenidate in tardive dyskinesia.
    Fann WE, Davis JM, Wilson IC.
    Am J Psychiatry; 1973 Aug; 130(8):922-4. PubMed ID: 4577471
    [No Abstract] [Full Text] [Related]

  • 2. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H, Chien CP, Cole JO.
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic approaches to tardive dyskinesia. A review of the literature.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P, Robotti E, Nardini M.
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract] [Full Text] [Related]

  • 9. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.
    Crane GE.
    Am J Psychiatry; 1968 Feb; 124(8):Suppl:40-8. PubMed ID: 4865731
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
    Longo V, Kemali D, Pacini A, Bertolino A, Lamura G.
    Boll Soc Ital Biol Sper; 1971 Aug 15; 47(15):470-2. PubMed ID: 5158530
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
    Gerlach J, Thorsen K, Munkvad I.
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar 15; 8(2):51-6. PubMed ID: 788002
    [Abstract] [Full Text] [Related]

  • 14. Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.
    Kazamatsuri H, Cole JO.
    Arch Gen Psychiatry; 1972 Dec 15; 27(6):824-7. PubMed ID: 4637899
    [No Abstract] [Full Text] [Related]

  • 15. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J, Floreánová L, Polák L.
    Act Nerv Super (Praha); 1972 Dec 15; 14(2):97. PubMed ID: 5040183
    [No Abstract] [Full Text] [Related]

  • 16. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May 15; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.